Proshrs Ultra Nq Bio (BIB) 44.18 $BIB Look for Shares of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proshrs Ultra Nq Bio (BIB) 44.18 $BIB

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback after Yesterday's 2.99% Rise
Comtex SmarTrend(R) - Tue May 31, 4:52PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $45.54 to a high of $46.80. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $45.15 on volume of 628,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 1.72% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:22PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $44.03 to a high of $45.14. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $45.10 on volume of 257,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

After Yesterday's Rally of 1.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 23, 3:18PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $41.26 to a high of $42.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $41.69 on volume of 446,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.85% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 18, 4:17PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $46.55 to a high of $49.05. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $47.93 on volume of 521,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 4.09% Yesterday
Comtex SmarTrend(R) - Mon Apr 04, 3:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $43.33 to a high of $45.17. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $43.44 on volume of 796,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

New Strong Buy Stocks for April 4th
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 9:14AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
ALGN: 79.69 (+0.32), BIB: 44.18 (-1.69), CNS: 39.58 (+0.34), AKG: 4.12 (+0.03), SFR: 28.24 (+0.18)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 5.95%
Comtex SmarTrend(R) - Thu Mar 31, 2:33PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $39.13 to a high of $41.53. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $41.48 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 33.7% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Feb 05, 5:44PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 33.67% as of today's recent price of $40.16.
BIB: 44.18 (-1.69)

Downtrend Call Working As ProShares Ultra Nasdaq Biotechnology ETF Stock Falls 30.1% (BIB)
Comtex SmarTrend(R) - Fri Jan 29, 5:04PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 3 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 30.07% as of today's recent price of $42.34.
BIB: 44.18 (-1.69)

BUYINS.NET: FXR, XIN, PRIM, HIL, MVV, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jan 25, 6:25AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Industrials/Producer Drbls AlphaDEX Fd (NYSE:FXR), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN), PRIMORIS SERVICES CORPORATION (NASDAQRIM), Hill International Inc (NYSE:HIL), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HIL: 4.55 (+0.05), PRIM: 20.97 (-0.59), MVV: 79.66 (-0.26), BIB: 44.18 (-1.69), XIN: 5.03 (+0.05), FXR: 28.90 (-0.14)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 18.5% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Jan 22, 12:48PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 18.46% as of today's recent price of $49.37.
BIB: 44.18 (-1.69)

BUYINS.NET: NOG, HTHT, BIB, KKR, HBM, JMP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Dec 18, 6:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Nordic Oil and Gas Ltd (NYSE:NOG), China Lodging Group Ltd (NASDAQ:HTHT), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), KKR & Co. L.P. (NYSE:KKR), HudBay Minerals Inc (NYSE:HBM), JMP Group Inc (NYSE:JMP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
NOG: 4.78 (-0.01), JMP: 5.41 (+0.07), BIB: 44.18 (-1.69), HBM: 4.96 (-0.03), KKR: 13.64 (-0.27), HTHT: 33.94 (-1.01)

BUYINS.NET: DFT, JKL, IYT, BIB, KKR, NOAH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 8:25PM CST
November 20, 2015
NOAH: 25.30 (-0.12), DFT: 46.56 (+0.24), BIB: 44.18 (-1.69), JKL: 126.57 (-0.68), KKR: 13.64 (-0.27), IYT: 141.87 (-0.27)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 2.04% Gain
Comtex SmarTrend(R) - Wed Nov 25, 5:25PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $70.60 to a high of $72.42. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $72.09 on volume of 493,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

BUYINS.NET: NEPT, SBH, AIMC, CVLT, MHH, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 23, 8:02AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Neptun SA (NASDAQ:NEPT), Sally Beauty Holdings Inc (NYSE:SBH), Altra Holdings Inc (NASDAQ:AIMC), CommVault Systems Inc (NASDAQ:CVLT), Mastech Holdings Inc (NYSE:MHH), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 44.18 (-1.69), SBH: 29.52 (-0.25), MHH: 6.52 (-0.35), CVLT: 47.24 (-0.01), AIMC: 28.60 (-0.10), NEPT: 1.12 (-0.05)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 1.04%
Comtex SmarTrend(R) - Mon Oct 19, 4:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $60.36 to a high of $65.30. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $64.21 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 44.18 (-1.69)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Elizabeth Warren Raises Concerns on Walgreens Sale to Private Equity

Updated Category News Views 235

Elizabeth Warren Voices Concern Over Walgreens Sale Senator Elizabeth Warren has taken a strong stance regarding Walgreens Boots Alliance's recent sale to the private-equity firm Sycamore Partners, valued at $10 billion. She expresses significant worries that this move, especially in light of the company's financial struggles, could exacerbate difficulties for workers and...

Continue Reading
Northrop Grumman Set to Release Q3 2025 Results and Webcast

Updated Category News Views 218

Upcoming Financial Results for Northrop Grumman Northrop Grumman Corporation (NYSE: NOC) has officially announced that it will be releasing its financial results for the third quarter of 2025. This eagerly anticipated announcement is scheduled for Tuesday, October 21, 2025, before the markets open. As a leader in aerospace and defense technology, the company continues to...

Continue Reading
Cannabist Company Launches Ric Flair Drip in New Jersey!

Updated Category News Views 655

Cannabist Company Expands Ric Flair Drip to New Jersey The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) has recently announced an exciting development in its partnership with the renowned cannabis brand Ric Flair Drip. This expansion into the New Jersey market follows a successful launch in Delaware and further establishes The Cannabist Company as a...

Continue Reading
Big Fig Mattress: A Bold Rebrand for Inclusive Comfort

Updated Category News Views 212

Big Fig Mattress Takes a Stand for Inclusivity Big Fig Mattress is making waves in the wellness industry by doubling down on its commitment to size inclusivity. The brand recently revealed a complete rebranding and an updated website that highlights its dedication to creating mattresses specifically for larger individuals. This initiative marks a significant moment in an...

Continue Reading
Pan African Resources Shareholder Value Through Growth Strategies

Updated Category News Views 204

Pan African Resources Celebrates a Successful Year In its latest financial results presentation, Pan African Resources (ticker: PAF) highlighted an exceptional year led by CEO Cobus Loots. The company saw a substantial 30% increase in profits, coupled with impressive dividend distributions. This success has been driven by rising gold prices, with production exceeding...

Continue Reading